News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
126 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21087)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (3)
2 (126)
3 (109)
4 (46)
5 (53)
6 (70)
7 (2)
8 (3)
9 (93)
10 (97)
11 (67)
12 (115)
13 (23)
16 (45)
17 (61)
18 (207)
19 (143)
20 (33)
21 (1)
22 (1)
23 (48)
24 (107)
25 (87)
26 (242)
27 (149)
29 (6)
30 (263)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
16
17
18
19
20
21
22
23
24
25
26
27
29
30
Business
Cingulate Therapeutics Appoints Laurie Myers, PhD, MBA as Chief Operating Officer
Dr. Myers currently serves as a founding member of the Cingulate Therapeutics Board of Directors.
April 2, 2018
·
3 min read
Business
Slayback Pharma Appoints Abhijit Mukherjee as Senior Advisor
Abhijit will advise the company on strategic and operational matters.
April 2, 2018
·
1 min read
Business
Macrolide Pharmaceuticals Appoints New President and CEO, Raises $20 Million in Investor Financing
Macrolide announced that Mahesh Karande has joined the company as President and CEO
April 2, 2018
·
3 min read
Pharm Country
Data Highlighting Advaxis’ ADXS-PSA Accepted as Poster Presentation at the American Society of Clinical Oncology Annual Meeting
The discussion will be presented and lead by author and principle investigator of the study, Mark Stein, MD, medical oncologist at Columbia University Medical Center.
April 2, 2018
·
3 min read
Biotech Bay
Twist Bioscience Completes $50 Million Financing to Fuel Advancement of Digital Storage in DNA and Drug Discovery
Completion of a private placement of $50 million, brings the total raised to $259 million since the company’s founding in 2013.
April 2, 2018
·
2 min read
Business
NuTek Food Science Announces Dr. Jon A. Vanderhoof as Chief Medical Officer
NuTek Food Science, LLC is pleased to announce that Dr. Jon A. Vanderhoof has joined the organization as Chief Medical Officer.
April 2, 2018
·
3 min read
Policy
MNA: National Labor Relations Board Issues Complaint against West Springfield-Based Trinity Health at Home for Refusing to Negotiate with Nurses
The National Labor Relations Board issued a formal complaint on Thursday against Trinity Health at Home for refusing to negotiate with its registered nurses and healthcare professionals.
April 2, 2018
·
2 min read
Business
Novus Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
In 2017, completed merger with Tokai Pharmaceuticals, Inc. and embarked on a mission to develop a novel, first-in-class treatment option for otitis media.
April 2, 2018
·
7 min read
Pharm Country
Cycle for Survival Raises A Record-Breaking $39 Million In 2018 For Rare Cancer Research
With support from founding partner Equinox, Cycle for Survival reaches a fundraising milestone; every dollar goes to rare cancer research led by Memorial Sloan Kettering Cancer Center
April 2, 2018
·
5 min read
Drug Development
Symic Bio Announces 12-Month Results from the SHIELD Trial of SB-030 in Peripheral Vascular Disease
- Data from 12-month follow-up demonstrates statistically significant improvement in clinical efficacy outcome - - Trial of SB-030 in prevention of vein graft failure in patients with advanced peripheral vascular disease planned to begin in the second half of 2018 -
April 2, 2018
·
4 min read
Previous
4 of 13
Next